home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Pokemon Protein Puts New Cancer Treatment On The Cards

  January, 25 2005 10:16
your information resource in human molecular genetics
In the 20 Jan 2005 issue of Nature (Vol. 433, No. 7023), scientists uncover the role of Pokemon, a key protein in cancer progression (pp. 278-285). The molecule is a promising new target for cancer drugs, and could be used to predict the likely course of the disease.

Pier Paolo Pandolfi and his colleagues found that mice cells lacking the gene for Pokemon were not transformed into cancerous, dividing cells even when cancer-triggering genes were ramped up inside them. Conversely, mice making excess Pokemon in their immune cells developed aggressive tumours. The protein can directly reduce production of a key tumour suppressor gene called ARF.

Pokemon is produced at very high levels in a subset of blood, breast, lung, colon, prostate and bladder cancers, the researchers show. Furthermore, the clinical outcome of a particular form of B-cell lymphoma can be predicted based on whether their cells are making Pokemon or not.


Pier Paolo Pandolfi
Memorial Sloan-Kettering Cancer Centre, New York, NY, USA.
Tel: +1 212 639 6168/8174
E-mail: p-pandolfi@ski.mskcc.org

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.